정밀 게놈 검사 시장 - 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 용도별, 기술별, 지역별 부문 예측(2025-2030년)

Precision Genomic Testing Market Trends:

The global precision genomic testing market size was estimated at USD 15.49 billion in 2024 and is projected to grow at a CAGR of 14.80% from 2025 to 2030, due to advancements in genomic technologies and an increasing emphasis on personalized medicine. This market encompasses a range of diagnostic tools and techniques used to analyze genetic information, leading to more accurate diagnoses, targeted therapies, and improved patient outcomes. The demand for precision genomic testing is driven by the need for early disease detection, effective treatment planning, and better management of chronic conditions.

Precision genomic testing, driven by CRISPR-Cas9 genome editing technology, is gaining momentum with continuous innovations and increasing investment in research and development. As a result, the market is poised for robust expansion in the coming years. For instance, in March 2024, The Advanced Genomics Collaboration (TAGC) awarded funding to four Innovation Projects led by the University of Melbourne in partnership with entities across the Melbourne Biomedical Precinct. These projects will also benefit from access to cutting-edge DNA sequencing technology at TAGC's world-class genomics hub, made possible through a collaboration between the University and global biotech firm Illumina, with backing from Invest Victoria.

The rising prevalence of genetic disorders and chronic diseases is driving the demand for precision genomic testing. An estimated 10,000 single-gene diseases result from mutations in a single gene, affecting approximately 10 out of every 1,000 people, according to the World Health Organization. This translates to nearly 70-80 million individuals worldwide living with such conditions. Disorders like cystic fibrosis, Huntington's disease, and various cancers significantly impact on patient health and quality of life. Early and accurate diagnosis is essential for effective treatment and management. Precision genomic testing enables the identification of disease-causing genetic mutations, allowing for timely interventions and personalized treatment plans. As the incidence of these conditions continues to rise, the need for reliable and comprehensive genomic testing solutions will drive market growth.

Additionally, collaborations among academic institutions, research organizations, healthcare providers, and biotechnology companies are accelerating market expansion. These partnerships foster innovation by facilitating knowledge exchange, resource sharing, and technological advancements. Strategic alliances with pharmaceutical firms further integrate precision genomic testing into drug development and personalized medicine. As the collaborative ecosystem grows, the precision genomic testing industry is expected to see sustained growth.

Global Precision Genomic Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global precision genomic testing market report based on product & service, application, technology, end use, and region:

• Product & Service Outlook (Revenue, USD Billion, 2018 - 2030)
• Consumables
  • Kits
  • Reagents
• Equipment
• Services
• Application Outlook (Revenue, USD Billion, 2018 - 2030)
• Oncology
• Cardiovascular Diseases
• Neurological Disorders
• Reproductive Health
• Rare Diseases
• Others
• Technology Outlook (Revenue, USD Billion, 2018 - 2030)
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microarray Technology
• Sanger Sequencing
• CRISPR/Cas Systems
• Others
• End Use Outlook (Revenue, USD Billion, 2018 - 2030)
• Hospitals & Clinics
• Diagnostic Laboratories
• Research & Academic Institutes
• Others
• Regional Outlook (Revenue, USD Billion, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Application Segment
  • 1.2.3. Technology Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Precision Genomic Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising demand for personalized medicine
    • 3.2.1.2. Advancements in genomic testing technology
    • 3.2.1.3. Increasing government funding & growing focus on genomic studies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Ethical and safety concerns related to precision genomic testing technologies
• 3.3. Precision Genomic Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis
• 3.4. Genomic Testing Cost Analysis
• 3.5. AI Applications in Genomic Testing

Chapter 4. Precision Genomic Testing Market: Product & Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Precision Genomic Testing Market Product & Service Movement Analysis
• 4.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Billion)
• 4.4. Consumables
  • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4.2. Kits
    • 4.4.2.1. Kits market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4.3. Reagents
    • 4.4.3.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Billion)
• 4.5. Equipment
  • 4.5.1. Equipment market estimates and forecasts, 2018 to 2030 (USD Billion)
• 4.6. Services
  • 4.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Precision Genomic Testing Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Precision Genomic Testing Market Application Movement Analysis
• 5.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
• 5.4. Oncology
  • 5.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.5. Cardiovascular Diseases
  • 5.5.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.6. Neurological Disorders
  • 5.6.1. Neurological disorders market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.7. Reproductive Health
  • 5.7.1. Reproductive health market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.8. Rare Diseases
  • 5.8.1. Rare diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.9. Others
  • 5.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Precision Genomic Testing Market: Technology Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Precision Genomic Testing Market Technology Movement Analysis
• 6.3. Global Precision Genomic Testing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
• 6.4. Next-Generation Sequencing
  • 6.4.1. Next-generation sequencing market estimates and forecasts, 2018 to 2030 (USD Billion)
• 6.5. Polymerase Chain Reaction
  • 6.5.1. Polymerase chain reaction market estimates and forecasts, 2018 to 2030 (USD Billion)
• 6.6. Microarray Technology
  • 6.6.1. Microarray technology market estimates and forecasts, 2018 to 2030 (USD Billion)
• 6.7. Sanger Sequencing
  • 6.7.1. Sanger sequencing market estimates and forecasts, 2018 to 2030 (USD Billion)
• 6.8. CRISPR/Cas Systems
  • 6.8.1. CRISPR/Cas systems market estimates and forecasts, 2018 to 2030 (USD Billion)
• 6.9. Others
  • 6.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Precision Genomic Testing Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Precision Genomic Testing Market End Use Movement Analysis
• 7.3. Global Precision Genomic Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Billion)
• 7.4. Hospitals and Clinics
  • 7.4.1. Hospitals and clinics market estimates and forecasts, 2018 to 2030 (USD Billion)
• 7.5. Diagnostic Laboratories
  • 7.5.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Billion)
• 7.6. Research & Academic Institutes
  • 7.6.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Billion)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 8. Precision Genomic Testing Market: Regional Estimates & Trend Analysis by Product & Service, Application, Technology, and End Use

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Billion)
• 8.5. Europe
  • 8.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.7. Denmark
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Competitive scenario
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.5.9. Norway
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Competitive scenario
    • 8.5.9.3. Regulatory framework
    • 8.5.9.4. Norway market estimates and forecasts, 2018 to 2030 (USD Billion)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Billion)
• 8.7. Latin America
  • 8.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Billion)
• 8.8. MEA
  • 8.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive scenario
    • 8.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Competitive scenario
    • 8.8.4.3. Regulatory framework
    • 8.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Competitive scenario
    • 8.8.5.3. Regulatory framework
    • 8.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Competitive Scenario
• 9.5. Company Profiles/Listing
  • 9.5.1. Danaher
    • 9.5.1.1. Company overview
    • 9.5.1.2. Financial performance
    • 9.5.1.3. Product & service benchmarking
    • 9.5.1.4. Strategic initiatives
  • 9.5.2. Merck KGaA
    • 9.5.2.1. Company overview
    • 9.5.2.2. Financial performance
    • 9.5.2.3. Product & service benchmarking
    • 9.5.2.4. Strategic initiatives
  • 9.5.3. Revvity, Inc.
    • 9.5.3.1. Company overview
    • 9.5.3.2. Financial performance
    • 9.5.3.3. Product & service benchmarking
    • 9.5.3.4. Strategic initiatives
  • 9.5.4. Maravai LifeSciences
    • 9.5.4.1. Company overview
    • 9.5.4.2. Financial performance
    • 9.5.4.3. Product & service benchmarking
    • 9.5.4.4. Strategic initiatives
  • 9.5.5. GenScript
    • 9.5.5.1. Company overview
    • 9.5.5.2. Financial performance
    • 9.5.5.3. Product & service benchmarking
    • 9.5.5.4. Strategic initiatives
  • 9.5.6. QIAGEN
    • 9.5.6.1. Company overview
    • 9.5.6.2. Financial performance
    • 9.5.6.3. Product & service benchmarking
    • 9.5.6.4. Strategic initiatives
  • 9.5.7. PacBio
    • 9.5.7.1. Company overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product & service benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. Oxford Nanopore Technologies plc.
    • 9.5.8.1. Company overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product & service benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. Illumina, Inc.
    • 9.5.9.1. Company overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product & service benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. 10x Genomics, Inc.
    • 9.5.10.1. Company overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product & service benchmarking
    • 9.5.10.4. Strategic initiatives